Zobrazeno 1 - 10
of 301
pro vyhledávání: '"John R Davies"'
Autor:
Samer Fawaz, Federico Marin, Sarosh A Khan, Rupert F G Simpson, Rafail A Kotronias, Jason Chai, Oxford Acute Myocardial Infarction (OxAMI) Study Investigators, Firas Al-Janabi, Rohan Jagathesan, Klio Konstantinou, Shah R Mohdnazri, Gerald J Clesham, Kare H Tang, Christopher M Cook, Keith M Channon, Adrian P Banning, John R Davies, Grigoris V Karamasis, Giovanni L De Maria, Thomas R Keeble
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 51, Iss , Pp 101374- (2024)
Background: The assessment of coronary microvascular dysfunction (CMD) using invasive methods is a field of growing interest, however the preferred method remains debated. Bolus and continuous thermodilution are commonly used methods, but weak agreem
Externí odkaz:
https://doaj.org/article/659aa0243cca4419aeb5a1ea4af6732d
Autor:
Sarosh Khan, MBBS, Rohan Jagathesan, MD, Olivia M.T. Frost, BSc, Iveta Crawford, BSc, Sheila Smith, BSc, Swamy Gedela, MBBS, Samer Fawaz, BMBS, Rupert Simpson, MBChB, Arvind Singh, MBBS, Grigoris V. Karamasis, MD, Thomas R. Keeble, MD, John R. Davies, PhD, Alamgir Kabir, PhD, Rajesh Aggarwal, MD, Christopher M. Cook, PhD
Publikováno v:
Structural Heart, Vol 8, Iss 1, Pp 100232- (2024)
Externí odkaz:
https://doaj.org/article/c6f508aacf084d7cab72e40612def80e
Autor:
Rupert F. G. Simpson, Josef Dankiewicz, Grigoris V. Karamasis, Paolo Pelosi, Matthias Haenggi, Paul J. Young, Janus Christian Jakobsen, Jonathan Bannard-Smith, Pedro D. Wendel-Garcia, Fabio Silvio Taccone, Per Nordberg, Matt P. Wise, Anders M. Grejs, Gisela Lilja, Roy Bjørkholt Olsen, Alain Cariou, Jean Baptiste Lascarrou, Manoj Saxena, Jan Hovdenes, Matthew Thomas, Hans Friberg, John R. Davies, Niklas Nielsen, Thomas R. Keeble
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-8 (2022)
Abstract Background Targeted temperature management (TTM) is recommended following cardiac arrest; however, time to target temperature varies in clinical practice. We hypothesised the effects of a target temperature of 33 °C when compared to normoth
Externí odkaz:
https://doaj.org/article/1b49f62482924e41af89166639f8b9c0
Autor:
Samer Fawaz, Daniel Munhoz, Thabo Mahendiran, Emanuele Gallinoro, Takuya Mizukami, Sarosh A. Khan, Rupert F. G. Simpson, Johan Svanerud, Christopher M. Cook, John R. Davies, Grigoris V. Karamasis, Bernard De Bruyne, Thomas R. Keeble
Publikováno v:
Diagnostics, Vol 14, Iss 3, p 285 (2024)
Continuous Thermodilution is a novel method of quantifying coronary flow (Q) in mL/min. To account for variability of Q within the cardiac cycle, the trace is smoothened with a 2 s moving average filter. This can sometimes be ineffective due to signi
Externí odkaz:
https://doaj.org/article/e9ab77c26d3d44aa963e23d4179f2cc0
Autor:
Klio Konstantinou, John R. Davies, Osama Alsanjari, Paul A. Kelly, Kare H. Tang, George Kassimis, Dimitrios Alexopoulos, Gerald J. Clesham, Thomas R. Keeble, Grigoris V. Karamasis
Publikováno v:
Hellenic Journal of Cardiology, Vol 66, Iss , Pp 11-18 (2022)
Objective: The impact of adjunctive manual thrombus aspiration (TA) in patients with stent thrombosis (ST) treated with percutaneous intervention has not been evaluated in the current era of potent P2Y12 agents and new-generation drug-eluting stents.
Externí odkaz:
https://doaj.org/article/926cec8e848741bb8dd3718527bcd6cd
Autor:
Sarosh Khan, Samer Fawaz, Rupert Simpson, Craig Robertson, Paul Kelly, Shah Mohdnazri, Kare Tang, Christopher M. Cook, Sean Gallagher, Peter O’Kane, James Spratt, Emmanouil S. Brilakis, Grigoris V. Karamasis, Rasha Al-Lamee, Thomas R. Keeble, John R. Davies
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPercutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) has been performed for the improvement of symptoms and quality of life in patients with stable angina. The ORBITA study demonstrated the role of the placebo
Externí odkaz:
https://doaj.org/article/4c054113640447388093f80b19c8d715
Autor:
Samer Fawaz, Sarosh Khan, Rupert Simpson, Gerald Clesham, Christopher M Cook, John R Davies, Grigoris Karamasis, Thomas R Keeble
Publikováno v:
Interventional Cardiology: Reviews, Research, Resources, Vol 18, Iss , Pp - (2023)
The landscape of interventional cardiology is ever evolving. Contemporary practice has shifted from a stenosis-centred approach to the total characterisation of both the epicardial and microcirculatory vessels. Microcirculatory dysfunction plays an i
Externí odkaz:
https://doaj.org/article/5821125eb01b4239ac5860902c7be8d7
Autor:
Marco Mion, Rosalind Case, Karen Smith, Gisela Lilja, Erik Blennow Nordström, Paul Swindell, Eleni Nikolopoulou, Jean Davis, Kelly Farrell, Ellie Gudde, Grigoris V. Karamasis, John R. Davies, William D. Toff, Benjamin S. Abella, Thomas R. Keeble
Publikováno v:
Resuscitation Plus, Vol 7, Iss , Pp 100154- (2021)
Background and objectives: Cognitive and physical difficulties are common in survivors of out-of-hospital cardiac arrest (OHCA); both survivors and close family members are also at risk of developing mood disorders. In the UK, dedicated follow-up pat
Externí odkaz:
https://doaj.org/article/af8ae3becd6b4478bb417400a166f8ef
Autor:
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon Barrans, Suzan van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon Rule, Nicola Crosbie, Andrew Clear, Maria Calaminici, Hendrik Runge, Robert K. Hills, David W. Scott, Lisa M. Rimsza, Geetha Menon, Chulin Sha, John R. Davies, Ai Nagano, Andrew Davies, Daniel Painter, Alexandra Smith, John Gribben, Kikkeri N. Naresh, David R. Westhead, Jessica Okosun, Andrew Steele, Daniel J. Hodson, Sriram Balasubramanian, Peter Johnson, Jun Wang, Jude Fitzgibbon
Publikováno v:
Blood Advances. 7:845-855
Despite the effectiveness of immuno-chemotherapy, 40% of patients with diffuse large B-cell lymphoma (DLBCL) experience relapse or refractory disease. Longitudinal studies have previously focused on the mutational landscape of relapse but fell short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16a708687638dec2a6b070dac5af5dc
https://doi.org/10.1182/bloodadvances.2022007536
https://doi.org/10.1182/bloodadvances.2022007536
Autor:
Michael Foley, Christopher A. Rajkumar, Matthew Shun‐Shin, Sashiananthan Ganesananthan, Henry Seligman, James Howard, Alexandra N. Nowbar, Thomas R. Keeble, John R. Davies, Kare H. Tang, Robert Gerber, Peter O’Kane, Andrew S. P. Sharp, Ricardo Petraco, Iqbal S. Malik, Sukhjinder Nijjer, Sayan Sen, Darrel P. Francis, Rasha Al‐Lamee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 3 (2021)
Background In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised
Externí odkaz:
https://doaj.org/article/9a0e900eb7d640c79a4e743aad6a6da5